Bain Capital Life Sciences Investors »

Alkermes shares owned by Bain Capital Life Sciences Investors

Quarter-by-quarter ownership of Alkermes (ALKS) shares owned by Bain Capital Life Sciences Investors from 13F filings

Historical chart of Bain Capital Life Sciences Investors investment in Alkermes

Tip: Access up to 7 years of quarterly data

All positions including Alkermes held by Bain Capital Life Sciences Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alkermes by Bain Capital Life Sciences Investors

Quarter filed Position value Share count Share price at filing
2026-03-31 $22M 610k 35.36

More positions owned by Bain Capital Life Sciences Investors

Heartflow Inc/Sh (HTFL)
Newamsterdam Pharma Company Ordinary Shares (NAMS)
Olema Pharmaceuticals (OLMA)
Savara (SVRA)
Pharvaris N V (PHVS)
Solid Biosciences Com New (SLDB)
X4 Pharmaceuticals Com New (XFOR)
Dianthus Therapeutics (DNTH)
Annexon (ANNX)
Kyverna Therapeutics (KYTX)
Cabaletta Bio (CABA)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Alkermes SHS (ALKS)
Rapid Micro Biosystems Class A Com (RPID)
C4 Therapeutics Com Stk (CCCC)

View all positions for Bain Capital Life Sciences Investors

Top funds holding Alkermes

BlackRock
Vanguard Group
Baker Bros. Advisors
Vanguard Portfolio Management
State Street Corporation
Vanguard Capital Management
Renaissance Technologies
American Century Companies
Dimensional Fund Advisors
Commodore Capital
Geode Capital Management
Deep Track Capital
Wellington Management Company
First Trust Advisors
PRIMECAP Management Company

View all funds holding Alkermes